Daewoong Pharmaceutical

South Korean publicly traded pharma company (KRX: 069620). Diversified pharmaceutical manufacturer spanning small molecules, biologics, and branded medicines. Note: primarily a finished-drug pharma company; a dedicated B2B peptide API supply offering is not clearly published.

Directory assessment: Daewoong Pharmaceutical is listed as a manufacturer in the peptide supply chain, serving Asia markets from South Korea. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 1 source for reference. This supplier has a moderate confidence score — buyers should perform additional due diligence before engaging.